Deep Tech Startups

Metrion Biosciences provides ion channel screening and drug discovery services for pharmaceutical and biotech companies. The company specializes in preclinical contract research operations with over 100 years of combined team expertise in ion channel biology.

2 investors

Mevea develops real-time simulation software and digital twin technology for product development and operator training across multiple industries including mining, ports, and marine equipment. The company serves industrial equipment manufacturers and operators seeking to reduce physical prototyping and enhance training through virtual simulation.

2 investors

MFX develops the Cyto Engine, an automated bioprocessing platform that accelerates development and manufacturing of engineered cells for cell and gene therapy. The platform combines scalable bioprocessing with analytics and data tools to increase access to these therapies.

2 investors

MicroAlign develops micro-actuator technology for high-precision fiber array alignment, enabling nanometer-scale positioning of optical fibers to photonic chips. The company serves applications in quantum photonic computing, data communication, and AI computing.

2 investors

Microamp develops proprietary 5G mmWave technology, including 3GPP-compliant mmWave radios and gNodeBs, to deliver high-speed, low-latency wireless connectivity. It serves industries and verticals seeking real-time access to and processing of large volumes of data.

2 investors

MicroLub is a UK-based deep-tech ingredient company that develops protein-based biolubricant molecules — protein microgels coated with polysaccharides — that reduce molecular friction to replace fats and oils in food and personal care products while retaining their mouthfeel and texture. It sells bespoke formulation solutions to R&D teams at food manufacturers, ingredient companies, and personal care brands.

2 investors

MICROOLED designs and manufactures high-resolution, low-power OLED microdisplays for near-eye applications including augmented reality glasses, night vision equipment, and medical devices. The company serves technology integrators, defense/security markets, and consumers through its ActiveLook sports augmented reality product line.

2 investors

MicroSeismic develops passive seismic monitoring technology for real-time subsurface insights in oil and gas, geothermal, and carbon capture operations. The company serves energy operators and resource extraction companies seeking to optimize hydraulic fracturing, monitor reservoir development, and verify carbon sequestration.

2 investors

Microsure develops a microsurgical robot that enables surgeons to perform operations on sub-millimeter anatomical structures with enhanced precision and comfort. The company aims to increase access to microsurgery by allowing specialists to work more effectively and treating more patients in need.

2 investors

MicroTau develops MAKO Flightfilm, a shark skin-inspired drag-reducing surface film applied to aircraft exteriors to improve aerodynamic efficiency and reduce fuel burn without structural modifications. It serves airlines and defense customers in the aviation sector.

2 investors

Mimetas provides microfluidic technology and services for 3D tissue culture research, offering pre-built tissue models, instrumentation, and platforms for pharmaceutical and safety testing applications.

2 investors

MindRhythm develops a portable, non-invasive medical device that uses the Headpulse algorithm and AI to triage stroke patients in the prehospital setting, helping paramedics identify Large Vessel Occlusion strokes and route patients to appropriate hospitals faster. The company targets emergency and neurological care providers in the stroke diagnostics market.

2 investors

Minpraxis offers materials testing and analysis services, including per meter sample testing, geometallurgical and geotechnical applications, and HPGR evaluation for the mining and mineral processing industries.

2 investors

Mirametrix develops software-only attention sensing technology using AI and computer vision for face, eye, and gaze tracking. It licenses this technology to consumer electronics and automotive companies for applications such as visual-hacking prevention, driver safety monitoring, productivity, and digital wellbeing.

2 investors

Mirror Physics offers Axon, a software product for drug discovery workflows that integrates with a team's existing tools, data, and infrastructure to surface insights and handle pipeline tasks. It targets drug discovery and pharmaceutical research teams.

2 investors

Mission BioCapital is a venture capital firm that invests in early-stage life science companies, from therapeutics and drug discovery to biotech tools and diagnostics. The firm provides capital, operational support, and lab infrastructure through its MBC BioLabs co-working spaces to help scientific entrepreneurs launch and scale biotech startups.

2 investors

Mission Control builds infrastructure for autonomous AI workers in enterprise settings, focusing on labor automation while emphasizing dignity and security in the machine economy.

2 investors

Mithril develops electrostatically actuated, reconfigurable antennas for space-based radar that provide phased-array-style adaptability without motors, gimbals, or deployment mechanisms, at lower cost and mass than phased arrays or deployable reflectors. Its single reconfigurable aperture supports radar and communications across MEO, GEO, and cislunar orbits, targeting defense and commercial space sensing applications.

2 investors

MMSense develops highly integrated millimeter wave multi-antenna, multi-transceiver beamforming systems spanning GHz to THz frequencies. Its technology targets sensing, 4D imaging, and wireless communication applications using RF/microwave/millimeter wave/Sub-THz components.

2 investors

Humans in Space develops health technologies for human operations in space environments, with applications to human health on Earth as well.

2 investors

Model Medicines is an AI-powered biotechnology company that uses computation to discover and engineer small molecule drugs targeting disease-driving biological mechanisms. The company has programs in infectious disease, oncology, and inflammation, with compounds in development including a broad-spectrum antiviral and a BRD4 inhibitor.

2 investors

Moeller Aerospace machines flight-critical turbine engine components and complex parts for major aerospace original equipment manufacturers and engine programs. The company specializes in precision machining of turbine airfoils and produces proprietary Click-Loc self-locking technology products.

2 investors

Mogrify is a biotechnology company developing in vivo cellular reprogramming therapies, using its proprietary MOGRIFY and epiMOGRIFY platforms that apply transcriptomic and epigenetic data to identify transcription factor combinations for converting one cell type into another. It targets diseases with high unmet clinical need, initially in otology, ophthalmology, and diabetes.

2 investors

A company that develops patented chemical formulations to control pest and vector populations through behavioral modification, serving applications in human health, agriculture, and livestock protection.

2 investors